Network meta-analysis of 95 RCTs (5898 antipsychotic-treated patients with schizophrenia spectrum disorders): vs placebo, semaglutide (−10.98 kg), liraglutide (−5.43 kg), topiramate, metformin and exenatide were associated with the largest weight loss (moderate certainty).
Meta-analysisn = 5,898
Stogios et al. Pharmacological Interventions for Weight Reduction in Patients With Schizophrenia Treated With Antipsychotics: A Systematic Review and Network Meta-Analysis